<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cureus</journal-id><journal-id journal-id-type="iso-abbrev">Cureus</journal-id><journal-id journal-id-type="issn">2168-8184</journal-id><journal-title-group><journal-title>Cureus</journal-title></journal-title-group><issn pub-type="epub">2168-8184</issn><publisher><publisher-name>Cureus</publisher-name><publisher-loc>Palo Alto (CA)</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28560121</article-id><article-id pub-id-type="pmc">5446220</article-id><article-id pub-id-type="doi">10.7759/cureus.1195</article-id><article-categories><subj-group subj-group-type="heading"><subject>Quality Improvement</subject></subj-group><subj-group><subject>Pain Management</subject></subj-group><subj-group><subject>Urology</subject></subj-group></article-categories><title-group><article-title>Comparison of Different Analgesia Drug Regimens for Pain Control During Extracorporeal Shock Wave Lithotripsy for Renal Stones: A Randomized Control Study</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Muacevic</surname><given-names>Alexander</given-names></name></contrib><contrib contrib-type="editor"><name><surname>Adler</surname><given-names>John R</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Waqas</surname><given-names>Muhammad</given-names></name><xref ref-type="aff" rid="aff-54260">1</xref></contrib><contrib contrib-type="author"><name><surname>Butt</surname><given-names>Amna</given-names></name><xref ref-type="aff" rid="aff-54260">1</xref></contrib><contrib contrib-type="author"><name><surname>Ayaz Khan</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="aff-54260">1</xref></contrib><contrib contrib-type="author"><name><surname>Khan</surname><given-names>Ijaz</given-names></name><xref ref-type="aff" rid="aff-57207">2</xref></contrib><contrib contrib-type="author"><name><surname>Saqib</surname><given-names>Imad-ud-din</given-names></name><xref ref-type="aff" rid="aff-58272">3</xref></contrib><contrib contrib-type="author"><name><surname>Hussain</surname><given-names>Tariq</given-names></name><xref ref-type="aff" rid="aff-58313">4</xref></contrib><contrib contrib-type="author"><name><surname>Akhter</surname><given-names>Saeed</given-names></name><xref ref-type="aff" rid="aff-54260">1</xref></contrib></contrib-group><aff id="aff-54260"><label>1</label>
Department of Urology, Shifa International Hospital, Islamabad, Pakistan </aff><aff id="aff-57207"><label>2</label>
Department of Urology, Pakistan Kidney Institute, Islamabad, Pakistan </aff><aff id="aff-58272"><label>3</label>
Department of Plastic Surgery, Shifa International Hospital, Islamabad, Pakistan </aff><aff id="aff-58313"><label>4</label>
Lithotripsy Department, Shifa International Hospital, Islamabad, Pakistan </aff><author-notes><corresp id="cor1">
Muhammad Waqas <email>waqas899@yahoo.com</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>26</day><month>4</month><year>2017</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>4</month><year>2017</year></pub-date><volume>9</volume><issue>4</issue><elocation-id>e1195</elocation-id><history><date date-type="received"><day>16</day><month>4</month><year>2017</year></date><date date-type="accepted"><day>26</day><month>4</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017, Waqas et al.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Waqas et al.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri xlink:href="http://www.cureus.com/articles/7022-comparison-of-different-analgesia-drug-regimens-for-pain-control-during-extracorporeal-shock-wave-lithotripsy-for-renal-stones-a-randomized-control-study">This article is available from http://www.cureus.com/articles/7022-comparison-of-different-analgesia-drug-regimens-for-pain-control-during-extracorporeal-shock-wave-lithotripsy-for-renal-stones-a-randomized-control-study</self-uri><abstract><sec><title>Introduction</title><p>With the increased use of extracorporeal shock wave lithotripsy (ESWL), the management of urolithiasis has become much convenient for the patients and the health care professionals alike. However, associated with the procedure is the common complaint of pain. No agreed upon pain management strategy has yet been developed for the procedure. We compared the effect of different analgesia drug regiments for pain control.</p></sec><sec><title>Methodology</title><p>A randomised controlled trial was carried out in Shifa International Hospital from between July 2015 to January 2016. A total of 135 patients were divided into three groups; group A received 30 g&#x000a0;lidocaine 2% gel applied locally on corresponding lumber area 30 minutes before the&#x000a0;procedure, group B received oral naproxen sodium 550 mg 45 minutes before the procedure, and group C received both oral naproxen and lidocaine gel. Patients were supplemented with intravenous nalbuphine during the&#x000a0;procedure. The&#x000a0;pain was assessed with 0-10 visual analogue scale. Both pre-procedure&#x000a0;and post-procedure pain score was measured.</p></sec><sec><title>Results</title><p>Among 135 patients,&#x000a0;105 (77.8%) were male and 29 (21.5%) were female with mean age of 38.7 &#x000b1; 1.31 years. There was no difference of mean pain score or&#x000a0;need for supplemental intravenous nalbuphine between groups&#x000a0;B and C but there was significantly decreased mean pain score and need for supplemental intravenous nalbuphine in groups&#x000a0;B and C in comparison with&#x000a0;group A.</p></sec><sec><title>Conclusion</title><p>The&#x000a0;use of oral naproxen sodium with or without the addition of lidocaine gel during ESWL is a promising option for pain management during the procedure with significant improvement in comparison with lidocaine gel alone.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>analgesia</kwd><kwd>extracorporeal shockwave lithotripsy</kwd><kwd>lidocaine gel</kwd><kwd>naproxen sodium</kwd><kwd>pain score</kwd></kwd-group></article-meta><notes><p content-type="disclaimer">The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.</p></notes></front><body><sec sec-type="intro"><title>Introduction</title><p>The introduction of extracorporeal shock wave lithotripsy (ESWL)&#x000a0;has revolutionized the treatment of urolithiasis due to it&#x000a0;being non-invasive in nature,&#x000a0;cost effective, and its associated reduced hospitalization time along with&#x000a0;lower morbidity [<xref rid="REF1" ref-type="bibr">1</xref>-<xref rid="REF2" ref-type="bibr">2</xref>]. The&#x000a0;impact of shock waves causes&#x000a0;pain in the&#x000a0;majority&#x000a0;of the patients,&#x000a0;requiring intervention for analgesia or sedation. It is important to keep the&#x000a0;patients&#x000a0;pain free to get the maximum possible success&#x000a0;rates.</p><p>Opioids are used most commonly for pain relief in ESWL but the associated&#x000a0;side effects require&#x000a0;patient monitoring and delayed hospital stay [<xref rid="REF3" ref-type="bibr">3</xref>-<xref rid="REF4" ref-type="bibr">4</xref>]. In some studies, nonsteroidal anti-inflammatory drugs (NSAIDs) have also shown&#x000a0;promising results with regards to&#x000a0;pain control without the side effects associated with&#x000a0;opioids [<xref rid="REF1" ref-type="bibr">1</xref>, <xref rid="REF5" ref-type="bibr">5</xref>]. Local analgesia gels have a controversial role in relieving pain in ESWL [<xref rid="REF1" ref-type="bibr">1</xref>, <xref rid="REF6" ref-type="bibr">6</xref>].</p><p>There are as yet no guidelines for pain relief during ESWL [<xref rid="REF1" ref-type="bibr">1</xref>, <xref rid="REF4" ref-type="bibr">4</xref>]. In this study, our intent was to compare the effect of local analgesia gel, oral NSAIDs, and their combination on pain during lithotripsy.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><p>We conducted a randomized control trial at the Department of Urology, Shifa International Hospital Islamabad. After institutional review board approval and written informed consent from the patients, we included all the patients who underwent ESWL from July 2015 to January 2016.</p><p>Patients were included&#x000a0;only&#x000a0;if they were older than 18 years, had renal stones, and understood the pain scoring system. All those patients who had any of the following were excluded; 1) history of chronic use of analgesia, 2) allergy to any of the used medications, 3) those having ureteric stones, 4) serum creatinine &#x0003e; 1.4, 5) pregnant patients, 6) those having gastric ulcer disease, 7) not willing to participate, 8) having any&#x000a0;coagulopathy, and 9) active urinary tract infection.</p><p>Patients were randomized into one of three groups by lottery method, groups A, B and C. Patients in group A&#x000a0;received&#x000a0;20 g lidocaine 2% gel application on the lumbar region corresponding to the entry site of the shockwaves, 30 minutes prior to&#x000a0;the procedure, patients&#x000a0;in group B&#x000a0;received&#x000a0;oral naproxen sodium 550 mg&#x000a0;45 minutes prior to the procedure while patients&#x000a0;in group C&#x000a0;received&#x000a0;both locally applied 2% lidocaine gel and oral naproxen sodium 550 mg per oral at the times mentioned previously.</p><p>We&#x000a0;used Modulith SLX lithotripter 4th&#x000a0;generation Storz (Kennesaw, GA, USA) medical equipment for ESWL. Before entering the procedure room,&#x000a0;patients were explained the procedure along with the visual analogue pain scale. Patients were asked to rate their pain on a scale from 0 (no pain) to 10 (maximum&#x000a0;pain). During the procedure,&#x000a0;pulse, blood pressure,&#x000a0;and&#x000a0;oxygen saturation were monitored. All patients were assessed by the same physician who was blinded to the patient group assignment. Analgesia was augmented with intravenous nalbuphine on patient demand during the procedure. Patients were monitored for ventilatory depression, decrease in oxygen saturation, nausea, vomiting, drowsiness, and hypersensitivity reactions for one hour after completion of the&#x000a0;procedure.</p><p>Shocks were delivered at low energy levels at the beginning of lithotripsy which was gradually increased to the recommended energy level. The number of shocks varied from 1800 to 4000 during a treatment session. Patients were discharged after completion of the procedure which was the basis of the fulfillment of the discharge criteria and were asked to follow up after one week.</p><p>Pain score was measured before the start of the procedure and then assessed immediately before giving intravenous nalbuphine in those who needed augmentation of analgesia during the procedure and post procedure in those who completed the procedure without any need for intravenous nalbuphine. The&#x000a0;number of shock waves and shock wave pressures at which nalbuphine was given was also noted.</p><p>Patients were compared for mean age,&#x000a0;gender, body mass index (BMI), analgesia requirement, the&#x000a0;number of shock waves tolerated without analgesia, the&#x000a0;total number of shock waves, peak shock wave pressure, and mean pain score. Data was collected on a specified pro forma, entered&#x000a0;and analysed using&#x000a0;IBM&#x000a0;SPSS version 16.0 (New York, USA). Chi-square test was used to analyse statistical significance of categorical variables.&#x000a0;The one-way analysis of variance (ANOVA) (least significant difference or LSD)&#x000a0;was&#x000a0;used to compare different groups with each other. A p-value of &#x0003c;0.05 was considered statistically significant.</p></sec><sec sec-type="results"><title>Results</title><p>A total of 135 patients with mean age of 38.7 &#x000b1; 1.31 years were included, 105 (77.8%) were male and 29&#x000a0;(21.5%) were females. There were 45 patients in each group. Demographic features of the three groups were comparable as&#x000a0;shown&#x000a0;in Table <xref ref-type="table" rid="TAB1">1</xref>.</p><table-wrap id="TAB1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Comparison of patient demographics and stone details</title><p>BMI: Body mass index;&#x000a0;DJ: Double J.</p></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">Group A</td><td rowspan="1" colspan="1">Group B</td><td rowspan="1" colspan="1">Group C</td></tr><tr><td rowspan="1" colspan="1">Mean Age</td><td rowspan="1" colspan="1">
40.87 &#x000b1; 12.32
</td><td rowspan="1" colspan="1">
36.04 &#x000b1; 13.20
</td><td rowspan="1" colspan="1">
39.33 &#x000b1; 13.84
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Gender
Male
Female
</td><td rowspan="1" colspan="1">
11 (24.4%)
34 (75.6%)
</td><td rowspan="1" colspan="1">&#x000a0;
5 (11.1%)
40 (88.9%)
</td><td rowspan="1" colspan="1">
14 (31.1%)
31 (68.9%)
</td></tr><tr><td rowspan="1" colspan="1">Mean BMI</td><td rowspan="1" colspan="1">
27.07 &#x000b1; 4.5
</td><td rowspan="1" colspan="1">
25.5 &#x000b1; 3.40
</td><td rowspan="1" colspan="1">
28.02 &#x000b1; 6.48
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Laterality
Left
Right</td><td rowspan="1" colspan="1">
25 (55.6%)
20 (44.4%)
</td><td rowspan="1" colspan="1">&#x000a0;
29 (64.4%)
16 (35.6%)
</td><td rowspan="1" colspan="1">&#x000a0;
31 (68.9%)
14 (31.1%)
</td></tr><tr><td rowspan="1" colspan="1">Mean Stone Size</td><td rowspan="1" colspan="1">
13.06 &#x000b1; 3.72
</td><td rowspan="1" colspan="1">
12.43 &#x000b1; 3.59
</td><td rowspan="1" colspan="1">
13.43 &#x000b1; 3.01
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Previous Lithotripsy<break/>
Yes<break/>
No
</td><td rowspan="1" colspan="1">&#x000a0;
19 (42.2%)
26 (57.8%)
</td><td rowspan="1" colspan="1">&#x000a0;
17 (37.8%)
28 (62.2%)
</td><td rowspan="1" colspan="1">
13 (28.9%)
31 (68.9%)
</td></tr><tr><td rowspan="1" colspan="1">
DJ stent<break/>
Yes<break/>
No
</td><td rowspan="1" colspan="1">&#x000a0;
22 (48.9%)
23 (51.1%)
</td><td rowspan="1" colspan="1">
23 (51.1%)
22 (48.9%)
</td><td rowspan="1" colspan="1">
17 (37.8%)
28 (62.2%)
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Opacity<break/>
Lucent<break/>
Faintly opaque<break/>
Opaque
</td><td rowspan="1" colspan="1">&#x000a0;
4 (8.9%)
2 (4.4%)
39 (86.7%)
</td><td rowspan="1" colspan="1">&#x000a0;
4 (8.9%)
8 (17.8%)
33 (73.3%)
</td><td rowspan="1" colspan="1">
6 (13.3%)
7 (15.6%)
32 (71.1%)
</td></tr><tr><td rowspan="1" colspan="1">
Stone Location
Upper pole<break/>
Middle pole<break/>
Lower pole<break/>
Pelvis
</td><td rowspan="1" colspan="1">&#x000a0;
6 (13.31%)
7 (15.6%)
21 (46.7%)
11 (24.4%)
</td><td rowspan="1" colspan="1">&#x000a0;
5 (11.1%)
13 (28.9%)
19 (42.2%)
8 (17.8%)
</td><td rowspan="1" colspan="1">&#x000a0;
4 (8.9%)
7 (15.6%)
21 (46.7%)
13 (28.9%)
</td></tr></tbody></table></table-wrap><p>Twenty-four (53.3%) patients in group A required&#x000a0;intravenous nalbuphine during&#x000a0;the&#x000a0;procedure compared to 13 (28.9%) patients in group B and 14 (31.1%) patients in group C. Higher&#x000a0;energy levels were noted for groups B and C&#x000a0;at which intravenous&#x000a0;analgesia was required as compared to group A (p-value = 0.000). Similarly, a&#x000a0;greater&#x000a0;number of shock waves&#x000a0;was observed&#x000a0;at which intravenous&#x000a0;analgesia was required in groups B and C as compared to group A (p-value = 0.085)&#x000a0;(Table <xref ref-type="table" rid="TAB2">2</xref>).</p><table-wrap id="TAB2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Outcomes of different variables analysed</title><p>IV: Intravenous.</p></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
&#x000a0;
</td><td rowspan="1" colspan="1">
Group A
</td><td rowspan="1" colspan="1">
&#x000a0;Group B
</td><td rowspan="1" colspan="1">
Group C
</td><td rowspan="1" colspan="1">
p-value
</td></tr><tr><td rowspan="1" colspan="1">
Mean pre-procedure pain score
</td><td rowspan="1" colspan="1">
0.11 &#x000b1; 0.44
</td><td rowspan="1" colspan="1">
0.13 &#x000b1; 0.40
</td><td rowspan="1" colspan="1">
0.11 &#x000b1; 0.38
</td><td rowspan="1" colspan="1">
0.957
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Mean number of shock&#x000a0;waves at which IV&#x000a0;analgesia required
</td><td rowspan="1" colspan="1">
1273.92 &#x000b1; 570.9
</td><td rowspan="1" colspan="1">
1675.85 &#x000b1; 454.3
</td><td rowspan="1" colspan="1">
1412.07 &#x000b1; 448.5
</td><td rowspan="1" colspan="1">
0.085
</td></tr><tr><td rowspan="1" colspan="1">
Mean energy level at which analgesia required&#x000a0;(KV)
</td><td rowspan="1" colspan="1">
15.42 &#x000b1; 0.717
</td><td rowspan="1" colspan="1">
16.62 &#x000b1; 0.51
</td><td rowspan="1" colspan="1">
16.43 &#x000b1; 0.85
</td><td rowspan="1" colspan="1">
0.000
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Number of patients requiring&#x000a0;IV&#x000a0;analgesia
</td><td rowspan="1" colspan="1">
24/45 (53.3%)
</td><td rowspan="1" colspan="1">
13/45 (28.9%)
</td><td rowspan="1" colspan="1">
14/45 (31.1%)
</td><td rowspan="1" colspan="1">
0.030
</td></tr><tr><td rowspan="1" colspan="1">
Mean maximum pain score
</td><td rowspan="1" colspan="1">
4.73 &#x000b1; 1.80
</td><td rowspan="1" colspan="1">
3.69 &#x000b1; 1.26
</td><td rowspan="1" colspan="1">
3.31 &#x000b1; 1.93
</td><td rowspan="1" colspan="1">
0.000
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Mean total&#x000a0;number of&#x000a0;shock&#x000a0;waves
</td><td rowspan="1" colspan="1">
3617.55 &#x000b1; 357.63
</td><td rowspan="1" colspan="1">
3606.67 &#x000b1; 289.51
</td><td rowspan="1" colspan="1">
3555.56 &#x000b1; 344.80
</td><td rowspan="1" colspan="1">
0.639
</td></tr><tr><td rowspan="1" colspan="1">
Mean maximum energy level (KV)
</td><td rowspan="1" colspan="1">
17.7 &#x000b1; 0.86
</td><td rowspan="1" colspan="1">
17.7 &#x000b1; 0.65
</td><td rowspan="1" colspan="1">
17.7 &#x000b1; 0.63
</td><td rowspan="1" colspan="1">
0.958
</td></tr></tbody></table></table-wrap><p>There was a&#x000a0;significantly lower number of patients requiring intravenous&#x000a0;analgesics in groups&#x000a0;B and C as compared to group A (p-value A vs B = 0.017 and A vs C = 0.029), while there was no significant difference between groups B vs&#x000a0;C (p-value = 0.826) (ANOVA) (Table <xref ref-type="table" rid="TAB3">3</xref>). The mean pain scores in groups&#x000a0;A, B, and C were 4.73 &#x000b1; 1.8, 3.69 &#x000b1; 1.3, and 3.3 &#x000b1; 1.9, respectively (Table <xref ref-type="table" rid="TAB2">2</xref>). There was significantly lower pain score in groups&#x000a0;B and C&#x000a0;as&#x000a0;compared to group A (p-value &#x0003c; 0.05) while no significant difference was seen between groups&#x000a0;B and C (Table&#x000a0;<xref ref-type="table" rid="TAB3">3</xref>).</p><table-wrap id="TAB3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Variables analysis among different groups (ANOVA, LSD)</title><p>ANOVA: Analysis of variance; IV:&#x000a0;Intravenous; LSD:&#x000a0;Least significant difference.</p></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Variables
</td><td rowspan="1" colspan="1">
Comparison
</td><td rowspan="1" colspan="1">
p-value
</td></tr><tr><td rowspan="1" colspan="1">
Mean number of shock&#x000a0;waves at which IV&#x000a0;analgesia was required
</td><td rowspan="1" colspan="1">
A &#x000a0;vs &#x000a0;B
A &#x000a0;vs &#x000a0;C
B &#x000a0;vs &#x000a0;C
</td><td rowspan="1" colspan="1">
0.027
0.426
0.187
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Mean energy level at which IV&#x000a0;analgesia&#x000a0;was&#x000a0;required
</td><td rowspan="1" colspan="1">
A &#x000a0;vs &#x000a0;B
A &#x000a0;vs &#x000a0;C
B &#x000a0;vs &#x000a0;C
</td><td rowspan="1" colspan="1">
0.000
0.000
0.499
</td></tr><tr><td rowspan="1" colspan="1">
Number of patients requiring&#x000a0;IV&#x000a0;analgesia
</td><td rowspan="1" colspan="1">
A &#x000a0;vs &#x000a0;B
A &#x000a0;vs &#x000a0;C
B &#x000a0;vs &#x000a0;C
</td><td rowspan="1" colspan="1">
0.017
0.029
0.826
</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">
Mean maximum pain score
</td><td rowspan="1" colspan="1">
A &#x000a0;vs &#x000a0;B
A &#x000a0;vs &#x000a0;C
B &#x000a0;vs &#x000a0;C
</td><td rowspan="1" colspan="1">
0.004
0.000
0.290
</td></tr></tbody></table></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>After its introduction by Chaussy&#x000a0;in 1980, ESWL&#x000a0;has become the standard treatment of choice for renal and ureteric stones. It is simple, noninvasive, ambulatory, effective, and associated with minimal comorbidities [<xref rid="REF1" ref-type="bibr">1</xref>-<xref rid="REF2" ref-type="bibr">2</xref>]. The pathogenesis of pain during ESWL is not clearly defined yet. It is proposed to be associated with stimulation of nociceptors in skin, renal capsule, pleural parietal peritoneum, and muscles [<xref rid="REF1" ref-type="bibr">1</xref>, <xref rid="REF4" ref-type="bibr">4</xref>].</p><p>Factors affecting the analgesia&#x000a0;requirement during ESWL are age, gender, the&#x000a0;amount of energy used, site and size of the&#x000a0;stone, shock wave peak pressure, type of lithotripter, size of the&#x000a0;focal zone, and cavitation effects [<xref rid="REF1" ref-type="bibr">1</xref>, <xref rid="REF7" ref-type="bibr">7</xref>]. With the introduction of new models of lithotripters, the trend for anesthesia has progressed&#x000a0;from general and regional anesthesia to sedative analgesic techniques [<xref rid="REF8" ref-type="bibr">8</xref>]. Pain during procedure results in&#x000a0;poor compliance. Poor analgesia&#x000a0;can make stone targeting more difficult resulting&#x000a0;in poor stone-free rates. Thus,&#x000a0;a pain-free patient is a better candidate&#x000a0;for ESWL to enhance the effectiveness of procedure [<xref rid="REF7" ref-type="bibr">7</xref>].</p><p>Different analgesics including opioids, NSAIDs, local analgesia and different combinations are used via&#x000a0;different routes. However,&#x000a0;there is&#x000a0;as yet no consensus on standard analgesia for pain during ESWL [<xref rid="REF1" ref-type="bibr">1</xref>, <xref rid="REF4" ref-type="bibr">4</xref>-<xref rid="REF5" ref-type="bibr">5</xref>]. Opioids are the most commonly used analgesics for pain control but they are associated with respiratory depression, bradycardia, hypotension, nausea, vomiting, and an extended monitoring time [<xref rid="REF9" ref-type="bibr">9</xref>].&#x000a0;Initially, NSAIDs and topical anesthetic creams were used as adjuncts with opioids to reduce their dose and side effects. With time, however,&#x000a0;in certain centers, they replaced opioids and started being used as&#x000a0;sole agents for pain relief&#x000a0;during the procedure&#x000a0;[<xref rid="REF10" ref-type="bibr">10</xref>].</p><p>Locally applied analgesic creams have a controversial role for pain control. Advantages include&#x000a0;their simplicity, non-invasiveness, avoiding the side effects of intramuscular and intravenous&#x000a0;analgesics, and their potential use as coupling medium [<xref rid="REF11" ref-type="bibr">11</xref>-<xref rid="REF12" ref-type="bibr">12</xref>]. Their disadvantage is that&#x000a0;they are relatively weak analgesics requiring other additional analgesics like opioids and NSAIDs for pain control [<xref rid="REF13" ref-type="bibr">13</xref>]. In most of the previous studies,&#x000a0;eutectic mixture of local analgesia (EMLA) cream (2.5% prilocaine and 2.5% lidocaine) was used as a&#x000a0;local analgesic. Considering the fact that&#x000a0;it is not easily available in Pakistan and its high cost,&#x000a0;we used 2% lidocaine gel, 30 minutes before the&#x000a0;procedure, for local analgesia.</p><p>Saita,&#x000a0;et al.&#x000a0;described&#x000a0;the role of intramuscular analgesia with locally applied Luan gel (lidocaine gel 1%) to decrease the discomfort during ESWL and to increase&#x000a0;the success rate of ESWL for ureteral and renal stones [<xref rid="REF14" ref-type="bibr">14</xref>]. Vilar, et al.,&#x000a0;in their analysis,&#x000a0;used intravenous pethidine and EMLA cream in one group and intravenous&#x000a0;pethidine and placebo cream in another group for pain control during ESWL. They concluded that EMLA cream combined with intravenous pethidine improved the&#x000a0;visual analogue score, stone fragmentation, and decreased rate of withdrawal from ESWL procedure versus intravenous&#x000a0;pethidine and placebo cream [<xref rid="REF15" ref-type="bibr">15</xref>]. Similarly,&#x000a0;Kumar, et al.&#x000a0;showed improved pain control and better stone-free rate with topical EMLA cream in combination with diclofenac sodium as&#x000a0;compared to either of the entities used alone [<xref rid="REF16" ref-type="bibr">16</xref>].</p><p>On the other hand,&#x000a0;Acar, et al.&#x000a0;in their study of 60 patients compared&#x000a0;EMLA with placebo cream before ESWL and patient controlled analgesia with remifentanil during the procedure and described no difference in the dose of remifentanil and pain score between the two groups [<xref rid="REF6" ref-type="bibr">6</xref>]. Eryildirim, et al. too&#x000a0;in their analysis of 120 patients compared&#x000a0;the effects&#x000a0;of EMLA cream alone, intramuscular diclofenac sodium alone, and their combination. They demonstrated that&#x000a0;no difference in pain control of patients was noted in patients using&#x000a0;diclofenac sodium with or&#x000a0;without EMLA cream and&#x000a0;instead&#x000a0;superior effect of intramuscular diclofenac sodium over EMLA cream was noted [<xref rid="REF17" ref-type="bibr">17</xref>].</p><p>The results of our study are consistent with those of Acar, et al.&#x000a0;and Eryildirim, et al. We found no significant difference among mean pain score and the need for supplemental intravenous analgesia between groups taking naproxen sodium with and without lidocaine gel. There was also no statistical difference in&#x000a0;energy levels and the number of shockwaves at which intravenous&#x000a0;analgesia was required between the aforementioned groups.</p><p>NSAIDs are considered more potent analgesics with fewer&#x000a0;side effects as compared to opioids for renal colic [<xref rid="REF18" ref-type="bibr">18</xref>].&#x000a0;They are equally effective as opioids for pain relief during ESWL. They provide effective pain relief through the inhibition of cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) enzymes. They are associated with mild gastrointestinal disturbances, occasional hypersensitivity reactions, and occasional&#x000a0;coagulation disorders [<xref rid="REF19" ref-type="bibr">19</xref>]. There are different NSAIDs in use&#x000a0;nowadays.</p><p>We used naproxen sodium 550 mg per oral 45 minutes before ESWL in our study. Naproxen sodium is one of the most commonly used NSAIDs. It has&#x000a0;the&#x000a0;lowest risk of vascular events when&#x000a0;compared to other NSAIDs [<xref rid="REF20" ref-type="bibr">20</xref>].&#x000a0;No previous study compared the analgesic effect of naproxen sodium for pain relief in ESWL.</p><p>Ozkan, et al.&#x000a0;compared the effect of lornoxicam (short acting NSAIDs), paracetamol, and tramadol for pre-procedural analgesia. They concluded that lornoxicam is a better analgesic than either paracetamol or tramadol [<xref rid="REF21" ref-type="bibr">21</xref>]. Iqbal, et al.&#x000a0;in their study described the superior role of intramuscular diclofenac sodium in combination with diclofenac gel as compared to diclofenac gel alone [<xref rid="REF8" ref-type="bibr">8</xref>]. Issa, et al.,&#x000a0;in their trial, reported better pain control and lower supplemental analgesia requirement with ketorolac as compared to morphine and EMLA cream [<xref rid="REF22" ref-type="bibr">22</xref>].</p><p>In our study when we used oral naproxen sodium with or without lidocaine gel,&#x000a0;there was a&#x000a0;significant reduction in both the mean pain score and the need for supplemental intravenous analgesia as compared to the use of&#x000a0;locally applied lidocaine gel alone. There were&#x000a0;significantly&#x000a0;high energy levels at which intravenous&#x000a0;analgesia was required in groups B and C as compared to group A. However,&#x000a0;approximately one-third of patients in both oral and mixed group needed rescue intravenous analgesia during the&#x000a0;procedure.</p><p>No patient in our study had any adverse drug reaction&#x000a0;thus&#x000a0;suggesting that the use of oral naproxen sodium is safe&#x000a0;for pain control during ESWL and may be augmented with on demand intravenous analgesia.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Due to the recent introduction of ESWL and lack of high-quality data regarding pain management strategies during the procedure, no standardised guidelines have been defined for analgesia use for ESWL.</p><p>Our study furthered the efforts made by previous investigators in comparing the effect of various analgesia options. A total of three strategies, lidocaine gel alone, oral naproxen alone and a combination of the two, were investigated. The variables being analysed included analgesia requirement, the&#x000a0;number of shock waves tolerated without analgesia, the&#x000a0;total number of shock waves, peak shock wave pressure, and mean pain score.</p><p>Our results demonstrated&#x000a0;that there was no significant effect of locally applied 2% lignocaine gel on mean pain score and intravenous analgesia requirement during ESWL procedure. However,&#x000a0;there was a statistically significant&#x000a0;lower pain score and lower supplemental analgesia requirement in patients taking oral naproxen sodium with or without lidocaine gel when compared with locally applied lignocaine gel alone.</p><p>We, therefore,&#x000a0;concluded that oral naproxen sodium with on demand intravenous analgesia is a safe and effective option for ESWL related pain. Further studies need to be conducted to compare its use with that of other pain management strategies such as the use of opioids with regards to their effects on the success rates of ESWL, mean pain score, adverse effects as well as the willingness of the patients to undergo the procedure in case of recurrence using the same pain management strategy.</p></sec></body><back><fn-group content-type="competing-interests"><fn fn-type="COI-statement"><p>The authors have declared that no competing interests exist.</p></fn></fn-group><fn-group content-type="other"><title>Human Ethics</title><fn fn-type="other"><p>Informed consent obtained.</p></fn></fn-group><fn-group content-type="other"><title>Animal Ethics</title><fn fn-type="other"><p><bold>Animal subjects:</bold> This study did not involve animal subjects or tissue.</p></fn></fn-group><ref-list><title>References</title><ref id="REF1"><label>1</label><element-citation publication-type="journal"><article-title>Analgesia for pain control during extracorporeal shock wave lithotripsy: current status</article-title><source>Indian J Urol</source><person-group><name><surname>Gupta</surname><given-names>NP</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name></person-group><fpage>155</fpage><lpage>158</lpage><volume>24</volume><year>2008</year><pub-id pub-id-type="pmid">19468389</pub-id></element-citation></ref><ref id="REF2"><label>2</label><element-citation publication-type="journal"><article-title>Extracorporeal shock-wave lithotripsy success rate and complications: initial experience at Sultan Qaboos University Hospital</article-title><source>Oman Med J</source><person-group><name><surname>Al-Marhoon</surname><given-names>MS</given-names></name><name><surname>Shareef</surname><given-names>O</given-names></name><name><surname>Al-Habsi</surname><given-names>IS</given-names></name><etal/></person-group><fpage>255</fpage><lpage>259</lpage><volume>28</volume><year>2013</year><pub-id pub-id-type="pmid">23904918</pub-id></element-citation></ref><ref id="REF3"><label>3</label><element-citation publication-type="journal"><article-title>The analgesic effect of inhalational Entonox for extracorporeal shock wave lithotripsy</article-title><source>Urol Res</source><person-group><name><surname>Mazdak</surname><given-names>H</given-names></name><name><surname>Abazari</surname><given-names>P</given-names></name><name><surname>Ghassami</surname><given-names>F</given-names></name><etal/></person-group><fpage>331</fpage><lpage>334</lpage><volume>35</volume><year>2007</year><pub-id pub-id-type="pmid">17982746</pub-id></element-citation></ref><ref id="REF4"><label>4</label><element-citation publication-type="journal"><article-title>Drugs for pain management in shock wave lithotripsy</article-title><source>Pain Res Treat</source><person-group><name><surname>Bach</surname><given-names>C</given-names></name><name><surname>Zaman</surname><given-names>F</given-names></name><name><surname>Kachrilas</surname><given-names>S</given-names></name><etal/></person-group><fpage>7</fpage><volume>2011</volume><year>2011</year></element-citation></ref><ref id="REF5"><label>5</label><element-citation publication-type="journal"><article-title>Effect of different analgesics on pain relief during extracorporeal shock wave lithotripsy</article-title><source>Hippokratia</source><person-group><name><surname>Yesil</surname><given-names>S</given-names></name><name><surname>Polat</surname><given-names>F</given-names></name><name><surname>Ozturk</surname><given-names>U</given-names></name><etal/></person-group><fpage>107</fpage><lpage>109</lpage><volume>18</volume><year>2014</year><uri xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201393/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201393/</uri><pub-id pub-id-type="pmid">25336870</pub-id></element-citation></ref><ref id="REF6"><label>6</label><element-citation publication-type="journal"><article-title>The effect of EMLA cream on patient-controlled analgesia with remifentanil in ESWL procedure: a placebo-controlled randomized study</article-title><source>Anesth Pain Med</source><person-group><name><surname>Acar</surname><given-names>A</given-names></name><name><surname>Erhan</surname><given-names>E</given-names></name><name><surname>Nuri Deniz</surname><given-names>M</given-names></name><etal/></person-group><fpage>119</fpage><lpage>122</lpage><volume>2</volume><year>2013</year><pub-id pub-id-type="pmid">24244921</pub-id></element-citation></ref><ref id="REF7"><label>7</label><element-citation publication-type="journal"><article-title>Entonox&#x000ae; inhalation to reduce pain in common diagnostic and therapeutic outpatient urological procedures: a review of the evidence</article-title><source>Ann R Coll Surg Engl</source><person-group><name><surname>Young</surname><given-names>A</given-names></name><name><surname>Ismail</surname><given-names>M</given-names></name><name><surname>Papatsoris</surname><given-names>A</given-names></name><etal/></person-group><fpage>8</fpage><lpage>11</lpage><volume>94</volume><year>2012</year><pub-id pub-id-type="pmid">22524905</pub-id></element-citation></ref><ref id="REF8"><label>8</label><element-citation publication-type="journal"><article-title>Analgesia for ESWL: comparing two analgesia techniques. A double blind randomized study</article-title><source>Internet J Urol</source><person-group><name><surname>Iqbal</surname><given-names>J</given-names></name><name><surname>Pall</surname><given-names>M</given-names></name><name><surname>Mette</surname><given-names>UK</given-names></name><etal/></person-group><volume>11</volume><year>2013</year><uri xlink:href="http://ispub.com/IJU/11/2/2953">http://ispub.com/IJU/11/2/2953</uri></element-citation></ref><ref id="REF9"><label>9</label><element-citation publication-type="journal"><article-title>Pain control using pethidine in combination with diazepam compared to diclofenac in combination with hyoscine-n-butyl bromide: in patients undergoing extracorporeal shock wave lithotripsy</article-title><source>Cent European J Urol</source><person-group><name><surname>Demir</surname><given-names>A</given-names></name><name><surname>Cecen</surname><given-names>K</given-names></name><name><surname>Karadag</surname><given-names>MA</given-names></name><etal/></person-group><fpage>201</fpage><lpage>206</lpage><volume>68</volume><year>2015</year></element-citation></ref><ref id="REF10"><label>10</label><element-citation publication-type="journal"><article-title>Comparison of ketorolac and diclofenac in the treatment of renal colic</article-title><source>Eur J Clin Pharmacol</source><person-group><name><surname>Cohen</surname><given-names>E</given-names></name><name><surname>Hafner</surname><given-names>R</given-names></name><name><surname>Rotenberg</surname><given-names>Z</given-names></name><etal/></person-group><fpage>455</fpage><lpage>458</lpage><volume>54</volume><year>1998</year><pub-id pub-id-type="pmid">9776434</pub-id></element-citation></ref><ref id="REF11"><label>11</label><element-citation publication-type="journal"><article-title>Choosing the correct pain relief for extracorporeal lithotripsy</article-title><source>Br J Urol</source><person-group><name><surname>Dawson</surname><given-names>C</given-names></name><name><surname>Vale</surname><given-names>JA</given-names></name><name><surname>Corry</surname><given-names>DA</given-names></name><etal/></person-group><fpage>302</fpage><lpage>307</lpage><volume>74</volume><year>1994</year><pub-id pub-id-type="pmid">7953259</pub-id></element-citation></ref><ref id="REF12"><label>12</label><element-citation publication-type="journal"><article-title>Local anesthesia for extracorporeal shock wave lithotripsy: a study comparing eutetic mixture of local anesthetics cream and lidocaine infiltration</article-title><source>J Urol</source><person-group><name><surname>Honnens de Lichtenberg</surname><given-names>M</given-names></name><name><surname>Miskowiak</surname><given-names>J</given-names></name><name><surname>Mogensen</surname><given-names>P</given-names></name><etal/></person-group><fpage>96</fpage><lpage>97</lpage><volume>147</volume><year>1992</year><uri xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/1729558/">https://www.ncbi.nlm.nih.gov/pubmed/1729558/</uri><pub-id pub-id-type="pmid">1729558</pub-id></element-citation></ref><ref id="REF13"><label>13</label><element-citation publication-type="journal"><article-title>Four analgesic techniques for shockwave lithotripsy: eutectic mixture local anesthetic is a good alternative</article-title><source>J Endourol</source><person-group><name><surname>Basar</surname><given-names>H</given-names></name><name><surname>Yilmaz</surname><given-names>E</given-names></name><name><surname>Ozcan</surname><given-names>S</given-names></name><etal/></person-group><fpage>3</fpage><lpage>6</lpage><volume>17</volume><year>2003</year><pub-id pub-id-type="pmid">12639353</pub-id></element-citation></ref><ref id="REF14"><label>14</label><element-citation publication-type="journal"><article-title>ESWL: comparing two analgesic techniques. Our experience</article-title><source>Urol Int</source><person-group><name><surname>Saita</surname><given-names>A</given-names></name><name><surname>Bonaccorsi</surname><given-names>A</given-names></name><name><surname>Aquilino</surname><given-names>M</given-names></name><etal/></person-group><fpage>46</fpage><lpage>47</lpage><volume>72</volume><year>2004</year></element-citation></ref><ref id="REF15"><label>15</label><element-citation publication-type="journal"><article-title>Topical&#x000a0;EMLA for pain control during extracorporeal shock wave lithotripsy: prospective, comparative, randomized, double-blind study</article-title><source>Urol Res</source><person-group><name><surname>Vilar</surname><given-names>DG</given-names></name><name><surname>Fadrique</surname><given-names>GG</given-names></name><name><surname>Sacoto</surname><given-names>CD</given-names></name><etal/></person-group><fpage>575</fpage><lpage>579</lpage><volume>40</volume><year>2012</year><pub-id pub-id-type="pmid">22555869</pub-id></element-citation></ref><ref id="REF16"><label>16</label><element-citation publication-type="journal"><article-title>Comparison of three analgesic regimens for pain control during shockwave lithotripsy using Dornier Delta Compact lithotripter: a randomized clinical trial</article-title><source>J Endourol</source><person-group><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>&#x000a0;Gupta</surname><given-names>NP</given-names></name><name><surname>&#x000a0;Hemal</surname><given-names>AK</given-names></name><etal/></person-group><fpage>578</fpage><lpage>582</lpage><volume>21</volume><year>2007</year><pub-id pub-id-type="pmid">17638549</pub-id></element-citation></ref><ref id="REF17"><label>17</label><element-citation publication-type="journal"><article-title>Comparison of three analgesic treatment protocols for pain management during extracorporeal shock wave lithotripsy</article-title><source>Urol Int</source><person-group><name><surname>Eryildirim</surname><given-names>B</given-names></name><name><surname>Kuyumcuoglu</surname><given-names>U</given-names></name><name><surname>Tarhan</surname><given-names>F</given-names></name><etal/></person-group><fpage>276</fpage><lpage>279</lpage><volume>82</volume><year>2009</year><pub-id pub-id-type="pmid">19440013</pub-id></element-citation></ref><ref id="REF18"><label>18</label><element-citation publication-type="journal"><article-title>Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic</article-title><source>BMJ</source><person-group><name><surname>Holdgate</surname><given-names>A</given-names></name><name><surname>Pollock</surname><given-names>T</given-names></name></person-group><fpage>1401</fpage><volume>328</volume><year>2004</year><pub-id pub-id-type="pmid">15178585</pub-id></element-citation></ref><ref id="REF19"><label>19</label><element-citation publication-type="journal"><article-title>Meta-analysis of the efficacy of non-steroidal anti-inflammatory drugs vs. opioids for SWL using modern electromagnetic lithotripters</article-title><source>Int. braz j urol</source><person-group><name><surname>Mezentsev</surname><given-names>VA</given-names></name></person-group><fpage>293</fpage><lpage>298</lpage><volume>35</volume><year>2009</year><pub-id pub-id-type="pmid">19538764</pub-id></element-citation></ref><ref id="REF20"><label>20</label><element-citation publication-type="journal"><article-title>Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials</article-title><source>BMJ</source><person-group><name><surname>Kearney</surname><given-names>PM</given-names></name><name><surname>Baigent</surname><given-names>C</given-names></name><name><surname>Godwin</surname><given-names>J</given-names></name><etal/></person-group><fpage>1302</fpage><lpage>1308</lpage><volume>332</volume><year>2006</year><pub-id pub-id-type="pmid">16740558</pub-id></element-citation></ref><ref id="REF21"><label>21</label><element-citation publication-type="journal"><article-title>Comparison of three different&#x000a0;analgesic&#x000a0;protocols during shockwave&#x000a0;lithotripsy</article-title><source>J Endourol</source><person-group><name><surname>Ozkan</surname><given-names>F</given-names></name><name><surname>&#x000a0;Erdemir</surname><given-names>F</given-names></name><name><surname>&#x000a0;Erkorkmaz</surname><given-names>U</given-names></name><etal/></person-group><fpage>691</fpage><lpage>696</lpage><volume>26</volume><year>2012</year><pub-id pub-id-type="pmid">22050496</pub-id></element-citation></ref><ref id="REF22"><label>22</label><element-citation publication-type="journal"><article-title>Analgesia during extracorporeal shock wave lithotripsy using the Medstone STS lithotriptor: a randomized prospective study</article-title><source>Urology</source><person-group><name><surname>Issa</surname><given-names>MM</given-names></name><name><surname>&#x000a0;El-Galley</surname><given-names>R</given-names></name><name><surname>&#x000a0;McNamara</surname><given-names>DE</given-names></name><etal/></person-group><fpage>625</fpage><lpage>628</lpage><volume>54</volume><year>1999</year><pub-id pub-id-type="pmid">10510918</pub-id></element-citation></ref></ref-list></back></article>